NCT04981639

Brief Summary

It is important to decrease the postoperative pain in patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. We will compare the Transversus abdominis plane block with the Transversus abdominis plane block plus intramuscular electrical stimulation in patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Aug 2021

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
23 days until next milestone

Study Start

First participant enrolled

August 21, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2022

Completed
Last Updated

October 10, 2022

Status Verified

October 1, 2022

Enrollment Period

10 months

First QC Date

July 25, 2021

Last Update Submit

October 6, 2022

Conditions

Keywords

hyperthermic intra-peritoneal chemotherapy

Outcome Measures

Primary Outcomes (1)

  • Pain score

    Pain score will be measured using visual analogue scale (0: no pain, 10: worst imaginable pain) at postoperative day 1.

    At postoperative day 1

Secondary Outcomes (7)

  • Pain score

    At postoperative day 2, 3, 5, 7, 14 and 28

  • IVPCA consumption

    At postoperative day 1, 2, and 3

  • Nausea will be evaluated using 2 point scale (yes, no)

    At postoperative day 1, 2, 3, 5 and 7

  • Vomiting will be evaluated using 2 point scale (yes, no)

    at postoperative day 1, 2, 3, 5 and 7.

  • Peak cough flow

    At postoperative day -1, 4, 7, 14, and 28

  • +2 more secondary outcomes

Study Arms (3)

I (IVPCA)

ACTIVE COMPARATOR

Intravenous patient controlled analgesia will be performed.

Procedure: IVPCA

II (IVPCA+TAP)

ACTIVE COMPARATOR

Intravenous patient controlled analgesia and transversus abdominis plane block will be performed.

Procedure: TAP

III (IVPCA, IMS, and TAP)

ACTIVE COMPARATOR

Intravenous patient controlled analgesia, transversus abdominis plane block, and intramuscular muscular stimulation will be performed.

Procedure: IMS

Interventions

IVPCAPROCEDURE

Intravenous patient controlled analgesia will be performed.

I (IVPCA)
TAPPROCEDURE

Transversus abdominis plane block will be performed.

II (IVPCA+TAP)
IMSPROCEDURE

Intramuscular electrical stimulation will be performed.

III (IVPCA, IMS, and TAP)

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are able to do daily activity and walk independently.

You may not qualify if:

  • Patients with history of preoperative abdominal surgery
  • Patients who are unable to walk independently due to musculoskeletal disorder
  • Patients who are allergic to local anesthetics
  • Patients with chronic pain
  • Patients with pacemaker
  • Patients with endotracheal tube postoperatively
  • Patients with history of substance abuse
  • Pregnancy
  • Patients who are unable to communicate due to mental disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GangnamSeveranceHospital

Seoul, South Korea

Location

Related Publications (1)

  • Kim HC, Park J, Oh J, Kim M, Park EJ, Baik SH, Song Y. Analgesic effects of combined transversus abdominis plane block and intramuscular electrical stimulation in patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a randomized controlled trial. Int J Surg. 2023 May 1;109(5):1199-1207. doi: 10.1097/JS9.0000000000000383.

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 25, 2021

First Posted

July 29, 2021

Study Start

August 21, 2021

Primary Completion

June 14, 2022

Study Completion

June 14, 2022

Last Updated

October 10, 2022

Record last verified: 2022-10

Locations